{
    "Title": "Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers",
    "URL": "https://doi.org/10.1371/journal.pntd.0006020",
    "Published": "January 18, 2018",
    "Subject_Areas": [
        "Body weight",
        "Pharmacokinetics",
        "Adverse events",
        "Drug administration",
        "Blood plasma",
        "Drug therapy",
        "Tea",
        "Elimination half-life calculation"
    ],
    "Authors": {
        "Jose Muñoz": [
            "Barcelona Institute for Global Health, ISGlobal-CRESIB, Universitat de Barcelona. Barcelona, Spain"
        ],
        "Maria Rosa Ballester": [
            "CIM-Sant Pau. IIB Sant Pau. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau. Barcelona, Spain"
        ],
        "Rosa Maria Antonijoan": [
            "CIM-Sant Pau. IIB Sant Pau. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau. Barcelona, Spain",
            "Pharmacology and Therapeutics Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain"
        ],
        "Ignasi Gich": [
            "CIM-Sant Pau. IIB Sant Pau. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau. Barcelona, Spain",
            "Pharmacology and Therapeutics Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain"
        ],
        "Montse Rodríguez": [
            "CIM-Sant Pau. IIB Sant Pau. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau. Barcelona, Spain"
        ],
        "Enrico Colli": [
            "ExeltisPharma, Chemo group. Madrid, Spain"
        ],
        "Silvia Gold": [
            "Fundacion Mundo Sano, Buenos Aires, Argentina"
        ],
        "Alejandro J. Krolewiecki": [
            "Instituto de Investigaciones en Enfermedades Tropicales, Universidad Nacional de Salta/CONICET, Oran, Argentina"
        ]
    }
}